|
Immunotherapy
Citations 371-380 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
- Toshiaki Hayashi, Teru Hideshima, Masaharu Akiyama, Noopur Raje, Paul Richardson, Dharminder Chauhan, and Kenneth C. Anderson
Blood 2003; 102: 1435-1442.
[Abstract]
[Full text]
[PDF]
Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell–dependent immunity to B-cell lymphoma
- Jamie Honeychurch, Martin J. Glennie, Peter W. M. Johnson, and Timothy M. Illidge
Blood 2003; 102: 1449-1457.
[Abstract]
[Full text]
[PDF]
cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity
- Joseph A. Francisco, Charles G. Cerveny, Damon L. Meyer, Bruce J. Mixan, Kerry Klussman, Dana F. Chace, Starr X. Rejniak, Kristine A. Gordon, Ron DeBlanc, Brian E. Toki, Che-Leung Law, Svetlana O. Doronina, Clay B. Siegall, Peter D. Senter, and Alan F. Wahl
Blood 2003; 102: 1458-1465.
[Abstract]
[Full text]
[PDF]
Multidrug resistance protein attenuates gemtuzumab ozogamicin–induced cytotoxicity in acute myeloid leukemia cells
- Roland B. Walter, Brian W. Raden, Tom C. Hong, David A. Flowers, Irwin D. Bernstein, and Michael L. Linenberger
Blood 2003; 102: 1466-1473.
[Abstract]
[Full text]
[PDF]
Interleukin-7 improves T-cell recovery after experimental T-cell–depleted bone marrow transplantation in T-cell–deficient mice by strong expansion of recent thymic emigrants
- Annoek E. C. Broers, Sandra J. Posthumus-van Sluijs, Hergen Spits, Bronno van der Holt, Bob Löwenberg, Eric Braakman, and Jan J. Cornelissen
Blood 2003; 102: 1534-1540.
[Abstract]
[Full text]
[PDF]
Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor
- Sylvie Villard, Sébastien Lacroix-Desmazes, Thomas Kieber-Emmons, Dominique Piquer, Sabrina Grailly, Abdellah Benhida, Srini V. Kaveri, Jean-Marie Saint-Remy, and Claude Granier
Blood 2003; 102: 949-952.
[Abstract]
[Full text]
[PDF]
Synergy between tumor immunotherapy and antiangiogenic therapy
- Smita Nair, David Boczkowski, Benjamin Moeller, Mark Dewhirst, Johannes Vieweg, and Eli Gilboa
Blood 2003; 102: 964-971.
[Abstract]
[Full text]
[PDF]
Expression of CD52 on plasma cells in plasma cell proliferative disorders
- Shaji Kumar, Teresa K. Kimlinger, John A. Lust, Kathleen Donovan, and Thomas E. Witzig
Blood 2003; 102: 1075-1077.
[Abstract]
[Full text]
[PDF]
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen
- Mohamad Mohty, Jacques-Olivier Bay, Catherine Faucher, Bachra Choufi, Karin Bilger, Olivier Tournilhac, Norbert Vey, Anne-Marie Stoppa, Diane Coso, Christian Chabannon, Patrice Viens, Dominique Maraninchi, and Didier Blaise
Blood 2003; 102: 470-476.
[Abstract]
[Full text]
[PDF]
IVIg-mediated amelioration of murine ITP via Fc RIIB is independent of SHIP1, SHP-1, and Btk activity
- Andrew R. Crow, Seng Song, John Freedman, Cheryl D. Helgason, R. Keith Humphries, Katherine A. Siminovitch, and Alan H. Lazarus
Blood 2003; 102: 558-560.
[Abstract]
[Full text]
[PDF]
|
|
